Tokyo, Japan

Kyoichi Maeno


 

 

Average Co-Inventor Count = 9.4

ph-index = 3

Forward Citations = 48(Granted Patents)


Location History:

  • Tsukuba, JP (2006)
  • Tokyo, JP (2013 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Mind of Kyoichi Maeno

Introduction

Kyoichi Maeno, an accomplished inventor based in Tokyo, Japan, is noted for his significant contributions to pharmaceutical advancements, holding a total of nine patents. His work focuses on addressing various medical conditions, particularly those related to the gastrointestinal and urinary systems.

Latest Patents

One of Maeno's latest innovations includes a patent for a tetrahydroisoquinolin-1-one derivative or salt thereof. This compound shows promise as a therapeutic agent for irritable bowel syndrome (IBS). It has been found to possess excellent antagonistic action on bombesin 2 (BB2) receptors, making it highly effective for bowel movement disorders. Thus, this derivative can serve as a valuable therapeutic option for diseases associated with BB2 receptors, especially IBS.

Additionally, Maeno has developed a piperazine derivative aimed at being an MCreceptor agonist. His research led to the discovery that this derivative demonstrates beneficial actions associated with MCreceptor agonists. As a result, it can be utilized to prevent or treat various bladder and urinary tract diseases, including underactive bladder and voiding dysfunctions related to benign prostatic hyperplasia.

Career Highlights

Throughout his career, Maeno has worked with reputable companies in the pharmaceutical industry, including Seldar Pharma Inc. and Astellas Pharma GmbH. His expertise and innovative mindset have allowed him to make notable strides in the field of medicinal chemistry.

Collaborations

Kyoichi Maeno has collaborated with other talented professionals, including Itsuro Shimada and Takafumi Shimizu. These collaborations have been instrumental in advancing his research and developing pharmaceutical compounds that address critical health issues.

Conclusion

Kyoichi Maeno's inventive work continues to make a substantial impact in the pharmaceutical industry. With a focus on developing effective therapeutic agents, his contributions have the potential to improve the quality of life for many individuals suffering from gastrointestinal and urinary tract disorders. His patents serve as a testament to his dedication to innovation and the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…